Cardiac Marker Testing Devices Market Continues To Expand As Ortho Clinical Diagnostics Launches New Microtip Partnership Assays For Diabetes, Cardiac, And Rental Testing In Collaboration With Diazyme Laboratories Inc.

Cardiac Marker Testing Devices Market


 Cardiac markers are special antibodies measured in the blood to measure heart function. They can also be used in the detection or early diagnosis of certain diseases. Although they're usually associated with myocardial infarction, they can also be indicative of many other conditions. For instance, hyperthyroidism and thyroid prophylaxis can result in an elevated elevation in plasma marker levels.

Growing burden of cardiovascular diseases is stimulating the demand for cardiac maker testing devices significantly. Cardiac markers are biomarkers measured to evaluate heart function and thus they can be useful in the early prediction of diagnosis of diseases. According to the American Heart Association (AMA), in 2016, cardiovascular disease accounted for 17.6 million deaths across the globe. According to the same source, that number is expected to reach 23.6 million by 2030. Furthermore, according to the World Health Organization (WHO), around 17.9 million people die each year from cardiovascular disease.

Although the relationship between cardiac disease and cardiac markers is currently not clear, patients with abnormal cardiac function should be investigated for possible development of these antibodies. It is possible that these markers can provide early diagnosis and subsequent treatment options for such diseases, and by detecting them early, more people can receive optimal care. Furthermore, researchers have identified a number of potential environmental and dietary factors that may increase the risk of cardiac disease and can help to identify which lifestyle and dietary habits may be responsible. High geriatric population is another factor that researchers have identified, which can accelerate the demand for cardiac maker testing devices since elderly people are more susceptible to heart-related diseases.

However, there have been numerous concerns regarding these devices, primarily the collection and storage of samples. Some devices have found to be inefficient in collecting the samples and storing them efficiently. Besides, stringent regulatory compliance policies are making it difficult for manufacturers to boost their sales. Thus, such factors can affect negatively the cardiac marker testing devices market

As the technology that supports the monitoring of heart health continues to advance, it will be easier and more effective to monitor patients with cardiac disease and monitor their markers. Medical researchers have been able to develop several different tests to measure these proteins and are developing new methods to keep up with the latest developments. The developed regions such as North America and Europe offer a massive opportunity for medical researchers due to the presence of robust research facilities and being home to major device manufacturers. Hence, cardiac marker testing devices have witnessed significant demand in the above-mentioned regions. 

Recently, in July 2018, Ortho Clinical Diagnostics launched new MicroTip partnership assays for diabetes, cardiac, and rental testing in collaboration with Diazyme Laboratories Inc. 

Comments

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)